Home/Filings/4/0001415889-21-000692
4//SEC Filing

CORZO DEYA 4

Accession 0001415889-21-000692

CIK 0001821323other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 8:00 AM ET

Size

5.5 KB

Accession

0001415889-21-000692

Insider Transaction Report

Form 4
Period: 2021-02-11
CORZO DEYA
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-11+55,00055,000 total
    Exercise: $39.81Exp: 2031-02-10Common Stock (55,000 underlying)
Footnotes (1)
  • [F1]The option vest as to 25% of the underlying shares of common stock on February 11, 2022, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested.

Issuer

Sigilon Therapeutics, Inc.

CIK 0001821323

Entity typeother

Related Parties

1
  • filerCIK 0001834115

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 8:00 AM ET
Size
5.5 KB